These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pituitary adenylate cyclase activating-peptide and its receptor antagonists in development of acute pancreatitis in rats. Chen YD, Zhou ZG, Wang Z, Gao HK, Yan WW, Wang C, Zhao GP, Peng XH. World J Gastroenterol; 2005 Jan 28; 11(4):538-44. PubMed ID: 15641142 [Abstract] [Full Text] [Related]
3. [On PACAP-aggravated experimental acute pancreatitis]. Chen Y, Zhou Z, Chen Y, Wang Z, Gao H, Zheng X. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec 28; 21(6):964-9. PubMed ID: 15646343 [Abstract] [Full Text] [Related]
4. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development. Borba JC, Henze IP, Silveira MS, Kubrusly RC, Gardino PF, de Mello MC, Hokoç JN, de Mello FG. Brain Res Dev Brain Res; 2005 May 12; 156(2):193-201. PubMed ID: 16099306 [Abstract] [Full Text] [Related]
5. Effects of in ovo treatment with PACAP antagonist on general activity, motor and social behavior of chickens. Hollósy T, Józsa R, Jakab B, Németh J, Lengvári I, Reglodi D. Regul Pept; 2004 Dec 15; 123(1-3):99-106. PubMed ID: 15518899 [Abstract] [Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells. Nagakawa O, Junicho A, Akashi T, Koizumi K, Matsuda T, Fuse H, Saiki I. Oncol Rep; 2005 Jun 15; 13(6):1217-21. PubMed ID: 15870945 [Abstract] [Full Text] [Related]
7. Effects of pituitary adenylate cyclase polypeptide (PACAP) on extinction of active avoidance learning in rats: involvement of neurotransmitters. Adamik A, Telegdy G. Regul Pept; 2005 Apr 15; 127(1-3):55-62. PubMed ID: 15680470 [Abstract] [Full Text] [Related]
8. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R. J Endocrinol; 2006 Oct 15; 191(1):287-99. PubMed ID: 17065411 [Abstract] [Full Text] [Related]
9. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R. Reproduction; 2007 Aug 15; 134(2):281-92. PubMed ID: 17660238 [Abstract] [Full Text] [Related]
11. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice. Rangon CM, Goursaud S, Medja F, Lelièvre V, Mounien L, Husson I, Brabet P, Jégou S, Janet T, Gressens P. J Pharmacol Exp Ther; 2005 Aug 07; 314(2):745-52. PubMed ID: 15872042 [Abstract] [Full Text] [Related]
12. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis. Isobe K, Kaneko M, Kaneko S, Nissato S, Nanmoku T, Takekoshi K, Okuda Y, Kawakami Y. Regul Pept; 2004 Dec 15; 123(1-3):29-32. PubMed ID: 15518890 [Abstract] [Full Text] [Related]
13. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jégou S. Neuroscience; 2006 Nov 17; 143(1):155-63. PubMed ID: 16962718 [Abstract] [Full Text] [Related]
14. Involvement of different receptors in pituitary adenylate cyclase activating polypeptide induced open field activity in rats. Adamik A, Telegdy G. Neuropeptides; 2004 Feb 17; 38(1):16-20. PubMed ID: 15003711 [Abstract] [Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland. Valiante S, Prisco M, Sciarrillo R, De Falco M, Capaldo A, Gay F, Andreuccetti P, Laforgia V, Varano L. J Endocrinol; 2008 Feb 17; 196(2):291-303. PubMed ID: 18252952 [Abstract] [Full Text] [Related]
16. Protective effect of central thyrotropin-releasing hormone analog on cerulein-induced acute pancreatitis in rats. Yoneda M, Goto M, Nakamura K, Shimada T, Hiraishi H, Terano A, Haneda M. Regul Pept; 2005 Feb 15; 125(1-3):119-24. PubMed ID: 15582722 [Abstract] [Full Text] [Related]
17. Neuroprotective action of endogenous PACAP in cultured rat cortical neurons. Shintani N, Suetake S, Hashimoto H, Koga K, Kasai A, Kawaguchi C, Morita Y, Hirose M, Sakai Y, Tomimoto S, Matsuda T, Baba A. Regul Pept; 2005 Mar 15; 126(1-2):123-8. PubMed ID: 15620425 [Abstract] [Full Text] [Related]
18. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock. Martínez C, Juarranz Y, Abad C, Arranz A, Miguel BG, Rosignoli F, Leceta J, Gomariz RP. J Leukoc Biol; 2005 May 15; 77(5):729-38. PubMed ID: 15661828 [Abstract] [Full Text] [Related]
19. Over-expression of pancreatic pituitary adenylate cyclase-activating polypeptide (PACAP) aggravates cerulein-induced acute pancreatitis in mice. Hamagami K, Sakurai Y, Shintani N, Higuchi N, Ikeda K, Hashimoto H, Suzuki A, Kiyama H, Baba A. J Pharmacol Sci; 2009 Aug 15; 110(4):451-8. PubMed ID: 19672038 [Abstract] [Full Text] [Related]